While the company has a strong balance sheet and management is optimistic about 2026, the significant revenue decline and large non-cash charges indicate fundamental business challenges. Traders should monitor the company's ability to achieve its guidance of sequential improvement and $1B+ revenue run-rate in 2026.
Price Chart
Executive Summary
Cross Country Healthcare reported a significant decline in financial performance for Q4 and full year 2025, with revenue down 24% YoY and a net loss of $94.9 million driven by a $77.9 million goodwill impairment charge and $29.6 million valuation allowance on deferred tax assets. Despite these losses, management highlighted positive cash flow, a strong balance sheet with $109 million in cash and no debt, and expects sequential improvement in 2026 driven by its Intellify technology platform.
Key Financial Metrics
Key Facts
- Revenue declined 24% YoY in Q4 and 22% for full year 2025
- $77.9 million goodwill impairment charge and $29.6 million valuation allowance on deferred tax assets drove net loss of $94.9 million
- Strong balance sheet with $109 million cash and no debt
- Management expects sequential progression throughout 2026 with goal of $1B+ revenue run-rate
- Repurchased 800,000 shares (2.5% of shares outstanding) in Q4
Financial Impact
Revenue down $289.7 million YoY, net loss increased by $80.3 million
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Nurse and Allied Staffing | $862.8M | -25.0% |
| Physician Staffing | $191.5M | -4.0% |
Risk Factors
- Continued revenue decline in travel staffing segment
- Integration challenges with Intellify platform
- Market skepticism about management's optimistic 2026 outlook given current performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-014650 |
| Document: ccrn-20260304.htm | 0001628280-26-014650 |
| Document: 0001628280-26-014650-index-headers.html | 0001628280-26-014650 |
| Document: 0001628280-26-014650-index.html | 0001628280-26-014650 |
| Document: 0001628280-26-014650.txt | 0001628280-26-014650 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 6, 2026 16w ago | 425 | $13.20 | awaiting T+20 | — | — |
Jul 6, 2026 16w ago | 8-K | $13.20 | awaiting T+20 | — | — |
Jun 15, 2026 19w ago | DEFM14A | $13.18 $13.22 | ▲ +0.30% | ▲ +0.10% | — |
Jun 3, 2026 20w ago | PREM14A | $13.19 $13.20 | ▲ +0.08% | ▲ +1.45% | — |
May 7, 2026 24w ago | DEFA14A | $13.18 $13.18 | · 0.00% | ▼ −0.02% | — |
May 7, 2026 24w ago | DEFA14A | $13.18 $13.18 | · 0.00% | ▼ −0.02% | — |
May 7, 2026 24w ago | 8-K | $13.18 $13.18 | · 0.00% | ▼ −0.02% | — |
May 7, 2026 24w ago | 8-K | $13.09 $13.12 | ▲ +0.23% | ▼ −2.91% | — |
Apr 17, 2026 27w ago | 8-K | $9.96 $13.10 | ▲ +31.53% | ▲ +27.32% | — |
Mar 4, 2026 33w ago | 8-K | $9.89 $9.18 | ▲ +7.18% | ▲ +3.39% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers